News & Events

NF1 treatment breakthrough
A commonly available nutritional supplement has inspired 11-year-old William Aberley’s self-confidence as he takes part in sports, both in and outside of school. This might seem ordinary, but not for William, who was diagnosed with Neurofibromatosis type 1 (NF1) as a toddler. NF1 is a hereditary genetic disorder affecting about 1 in 3,000 children worldwide. It’s commonly characterised by...
Read more
A joint-study between UNSW and the Sydney Children’s Hospitals Network (SCHN) has revealed a rise in mental health services used by children and adolescents after Sydney’s first lockdown in 2020. The new research, published in The Lancet Regional Health – Western Pacific, compared admissions from January 2020 to February 2021 to hospital records between 2016 and 2019, to observe how the use of...
Read more
Webinar Series
Watch the video of this webinar to hear from two experts in important parts of the drug development pipeline. So far, our series of webinars has featured a number of therapies currently being delivered to patients at the Sydney Children’s Hospitals Network (SCHN). So we’ve asked the experts how potential therapies are identified and how do we most effectively investigate the effectiveness and saf...
Read more